Halozyme Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $47M | 41M | 1.14 |
| 2025-06-30 | $35M | 35M | 0.99 |
| 2025-03-31 | $34M | 33M | 1.06 |
| 2024-12-31 | $31M | 33M | 0.95 |
| 2024-09-30 | $31M | 31M | 1.00 |